Although the sample size to achieved this conclusion was small, an in silico analysis using The Cancer Genome Atlas (TCGA)-Colorectal Cancer Dataset showed similar results: patients with high CSDE1 expression presented shorter mean progression-free survival than patients with low CSDE1 expression (Martinez-Useros et al., 2019). Here, CSDE1 is linked to colorectal cancer.